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Abstract
Background: The linkage between periodontal disease and rheumatoid arthritis is well established. Commonalities
among the two are that both are chronic inflammatory diseases characterized by bone loss, an association with the
shared epitope susceptibility allele, and anti-citrullinated protein antibodies.
Methods: To explore immune mechanisms that may connect the two seemingly disparate disorders, we measured
host immune responses including T-cell phenotype and anti-citrullinated protein antibody production in human
leukocyte antigen (HLA)-DR1 humanized C57BL/6 mice following exposure to the Gram-negative anaerobic
periodontal disease pathogen Porphyromonas gingivalis. We measured autoimmune arthritis disease expression in mice
exposed to P. gingivalis, and also in arthritis-resistant mice by flow cytometry and multiplex cytokine-linked and
enzyme-linked immunosorbent assays. We also measured femoral bone density by microcomputed tomography
and systemic cytokine production.
Results: Exposure of the gingiva of DR1 mice to P. gingivalis results in a transient increase in the percentage of
Th17 cells, both in peripheral blood and cervical lymph nodes, a burst of systemic cytokine activity, a loss in
femoral bone density, and the generation of anti-citrullinated protein antibodies. Importantly, these antibodies
are not produced in response to P. gingivalis treatment of wild-type C57BL/6 mice, and P. gingivalis exposure
triggered expression of arthritis in arthritis-resistant mice.
Conclusions: Exposure of gingival tissues to P. gingivalis has systemic effects that can result in disease pathology
in tissues that are spatially removed from the initial site of infection, providing evidence for systemic effects of
this periodontal pathogen. The elicitation of anti-citrullinated protein antibodies in an HLA-DR1-restricted fashion
by mice exposed to P. gingivalis provides support for the role of the shared epitope in both periodontal disease
and rheumatoid arthritis. The ability of P. gingivalis to induce disease expression in arthritis-resistant mice provides
support for the idea that periodontal infection may be able to trigger autoimmunity if other disease-eliciting
factors are already present.
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Background
Rheumatoid arthritis (RA) is a chronic, destructive pro-
inflammatory autoimmune disease with an as yet un-
known etiology. RA has both a genetic basis and lifestyle
components such as smoking. Among the genetic com-
ponents, expression of specific polymorphisms of human
leukocyte antigen (HLA)-DRβ1 (the so-called “shared
epitope” (SE)) is most frequently cited as enhancing the
risk of RA and predicting a worse outcome in individ-
uals expressing one or more susceptibility alleles that
encode a linear sequence of amino acids in the DRβ1
chain of the HLA‐DRα/β heterodimer between amino
acids 67 and 74 (QKRAA in *0401, QRRAA in *0404,
*0405, and *0101, and RRRAA in *1001) [1].
Periodontitis (PD) is a chronic inflammatory condition
in the periodontal tissues (gingiva, ligament, alveolar
bone) that shares many features in common with RA.
Like RA, PD results from chronic inflammation, in this
case directed toward gingival epithelium and spreading
to the underlying connective tissue. As in RA, it also
results in bone destruction, in this case alveolar bone
supporting the teeth. The pathology and inflammation
in both RA and PD are thought to be driven by proin-
flammatory Th17 cells which can be found both in the RA
synovial tissues and in inflamed gingiva [2]. While the
linkage between RA and PD is well documented (for re-
view, see [3]), studies elucidating the mechanism(s) driv-
ing this linkage are lacking.
One of the best studied periodontal pathogens is an
anaerobic, Gram-negative prokaryote known as Porphyr-
omonas gingivalis. This organism is a biofilm-forming
keystone-pathogen member of the so-called “red-complex”
of periodontal pathogens [4]. A recent study [5] found that
severity of PD and RA is related, in that RA patients
with severe PD have a more robust antibody response
against P. gingivalis than non-RA controls.
Another feature common to both RA and PD is the gen-
eration of antibodies directed against citrullinated pro-
teins. Proteins are citrullinated by the enzyme peptidyl
arginine deiminase (PAD) which deiminates the side chain
of arginine residues, converting them to citrulline. This
conversion results in the generation of neoepitopes
believed to induce the production of anti-citrullinated
protein antibodies (ACPAs). ACPAs are now used widely
as a diagnostic marker for RA because they are highly pre-
dictive of disease and are a very early marker that can be
detected long before the clinical expression of RA [6].
ACPAs can also be detected in the serum of patients with
periodontal disease [7]. It is therefore of great interest that
P. gingivalis is the only known prokaryote that encodes a
PAD enzyme in its genome [8], and is known both to
autocitrullinate and to modify host proteins as well [9].
We and others have shown that treatment with P.
gingivalis can alter the course of experimental arthritis
[10–13], and that a mouse which expresses human
HLA-DRβ1 as a transgene on the C57BL/6 background
reliably develops a high incidence of collagen-induced
arthritis. The use of HLA-DRβ1 humanized C57BL/6
mice allowed us to ask whether the DRβ1 transgene
might also alter the host response to P. gingivalis. Our
studies demonstrate that brushing the oral cavity of the
B6.DR1 gingiva with P. gingivalis results in a transient
increase in the percentage of Th17 cells in peripheral
blood and in cervical lymph nodes, a burst of systemic
cytokine activity, and generation of ACPAs. Importantly,
ACPAs produced in response to treatment with P. gingi-
valis are generated only by DRβ1-bearing mice and not in
C57BL/6 (WT) mice.
We also analyzed how this response impacted the
development of an ongoing autoimmune arthritis. We
determined that P. gingivalis treatment of mice which
had been challenged with type II collagen (CII) emulsified
in Complete Freund’s Adjuvant (CFA) resulted in a dra-
matic hastening of disease onset, increased incidence, and
enhanced severity of collagen-induced arthritis. Micro-
computed tomographic (μCT) analyses of nonarthritic
manus from mice brushed with P. gingivalis showed a
trend towards decreased bone density relative to manus
from unbrushed control mice, but once arthritis was trig-
gered both groups demonstrated an enhanced bone loss
that resulted in destruction of the form and function of
the bones analyzed.
Lastly, we also found that exposure of arthritis-resistant
mice (e.g., mice which had resisted the development of dis-
ease expression for months after others in the cohort had
developed disease) to P. gingivalis can serve as a trigger
that breaks their resistance and results in the expression of
overt clinical autoimmune arthritis.
These findings suggest that in the context of the appro-
priate susceptibility allele, infection with a red-complex
oral pathogen such as P. gingivalis may serve as an im-
portant factor that can tip the balance in favor of auto-
immunity and can either exacerbate existing disease or




We developed an I-A°/I-E° [14] mouse on the C57BL/6
background that expresses a chimeric mouse/human
RA/PD susceptibility allele HLA-DRβ1(*0101) as a trans-
gene as described previously [15]. Using a Foxp3gfp re-
porter (kind gift from Alexander Rudensky [16]) and an
IL-17Fmrfp reporter developed earlier [17], B6.DR1 mice
were crossed to facilitate the flow cytometric identification
and isolation of Treg and Th17 cells. Mice were carefully
screened to ensure the presence of all transgenes as
well as the absence of murine class II. All studies were
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performed under protocol 316941 which was approved
by the Institutional Animal Care and Use Committee at
the Memphis VA Medical Center.
Bacterial culture
P. gingivalis strain W83 was grown overnight in ATCC
2722 medium: tryptic soy broth supplemented with
hemin (5 mg/ml) and menadione (0.5 mg/ml) at 37 °C
in an anaerobic chamber equilibrated with a mixture of
90 % nitrogen, 5 % carbon dioxide, and 5 % hydrogen.
Bacterial cell counts were determined using a spectro-
photometer with an optical density of 1.0 at 600 nm
corresponding to 1 × 109 CFU/ml. Then 109 CFU/ml of
bacteria were harvested and washed three times in PBS,
and resuspended at 3.33 × 107/ml in PBS with 2 % car-
boxymethylcellulose (CMC).
Bacterial inoculation
Briefly, 10-12 week old B6.DR1 mice and/or C57BL/6
wild-type (WT) mice received Bactrim (sulfamethoxizole/
trimethoprim) in deionized water for 7 days. Three days
after the antibiotic treatment the mice were put under brief
isoflurane anesthesia, and 106 CFU of live P. gingivalis in
30 μl of PBS with 2 % CMC were administered using a
modification of the brush method used by Cantley et al.
[10]. Instead of dipping a brush in a solution of P. gingiva-
lis in CMC, we delivered the slurry through customized
tuberculin syringes to which plastic bristles had been
affixed in place of a needle. P. gingivalis was applied to the
gingival margin of mouse maxillary molars daily for 7 days.
A sham infected group received 30 μl of PBS with 2 %
CMC alone. In arthritis experiments, mice that had been
challenged with CII emulsified in CFA were brushed with
106 CFU of live P. gingivalis in 30 μl of PBS with 2 %
CMC without prior Bactrim treatment.
Flow cytometry
At specific time points before, during, and after brushing
with live P. gingivalis, peripheral blood was drawn and
stained with the following antibodies: Alexafluor 700 con-
jugated anti-mouse CD3ε, Peridinin Clorophyll/Cyanine
5.5 conjugated anti-mouse CD45, Pacific Blue conjugated
anti-mouse CD4, and Phycoerythrin/Cyanine 7 conjugated
anti-mouse CD25 (all BD Biosciences) prior to acquisition
on a SORP 5-Laser LSR II (BD Immunocytometry Sys-
tems). In some experiments, cervical lymph nodes were
obtained at the time of sacrifice and were subjected to the
same panel of antibodies. Analysis was performed using
FlowJo v10.1.
μCT analysis
Legs were harvested and fixed in 10 % neutral buffered
formalin solution for 72 hours and transferred to PBS
prior to dissecting femurs from the other leg tissues.
They were then stored and imaged in 70 % EtOH and
scanned with the following settings: 60 kV, 167 μA,
0.5 mm aluminum filter, 0.7° rotation step, 4 frames
averaging 2000 × 1336 CCD, 800 msec exposure, and
10 μm voxel size on a Skyscan 1172 instrument. Scan
time was 34 minutes.
The distal end of the volume of interest (VOI) started
1.5 mm proximally from the distal growth plate. It con-
tinued proximally for 1.5 mm. Trabecular bone was
isolated using an automated script and 3D morphomet-
ric analyses were performed.
For evaluation of cortical bone, the midpoint of the
VOI was located at 55 % of the total length of the femur
from the proximal end. The total length of the VOI was
1 mm. Cortical bone was isolated using an automated
script. 3D and 2D morphometric analyses were performed.
The 3D and 2D VOIs correspond to those described by
Bouxsein et al. [18].
Paw and whole leg scans were performed on a Scanco
μCT 40 using legs fixed in 10 % neutral buffered formalin.
They were imaged at an 8 μm voxel size at 55 kV with
145 μA over about 45 minutes.
Detection of antibodies to citrullinated protein antigens
WT (C57BL/6) mice or B6.DR1 mice (n = 5/group) were
brushed with live cultures of either WT P. gingivalis or
a PADnull mutant. Serum samples were obtained at the
times indicated and subjected to a commercial (Axis-Shield,
Alere, UK) ELISA according to the manufacturer’s instruc-
tions, including the selection of the appropriate mouse
secondary detection reagent.
Detection of P. gingivalis in blood and maxilla
Blood samples were obtained from B6.DR1 mice brushed
with live cultures of P. gingivalis or those left untreated.
Maxillae were harvested from mice 3 months following
the last treatment and were crushed under liquid nitrogen
in a mortar and pestle. Genomic DNA was obtained using
a DNeasy Blood & Tissue Kit according to the manufac-
turer’s instructions (Qiagen). PCR was performed accord-
ing to the methods of Marchesan et al. [19].
Cytokine analysis
Cytokines were measured in serum samples using the
Mouse Th17 6-plex (Bio-Rad) according to the manufac-
turer’s instructions and using internal standards supplied
with the kit. The limits of detection (in pg/ml) for each
analyte were as follows: IL-1β, 9.4; IL-6, 0.2; IL-10, 1.0;
IL-17A, 0.8; IFN-γ, 1.2; and TNF-α, 1.4.
Collagen-induced arthritis
Arthritis was induced in B6.DR1 mice following our
well-established protocol [20]. Thirty-nine B6.DR1 mice
were challenged with 100 μg of native bovine type II
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collagen (extracted and purified in our laboratory) emul-
sified in CFA made from 15 % (v/v) mannide monoole-
ate in heavy mineral oil. When the first clinical signs of
disease expression (paw swelling) were observed at day
26, cultures of P. gingivalis were initiated and the first
P. gingivalis treatments were started on 20 of the mice.
Treatments were performed daily for 7 days. Mice were
visually assessed for arthritis [20] both during and after
brushing.
Results
Rise in Th17 cell expression following treatment with
P. gingivalis
Flow cytometric analyses revealed that brushing the
gingival tissues of B6.DR1 mice resulted in a transient
increase in the percentage of circulating Th17 cells among
the peripheral blood mononuclear cells (PBMCs) relative
to untreated mice (Fig. 1). At baseline, less than 1 % of the
CD4+ T cells in the PBMCs were Th17-positive whereas
the level transiently rises to approximately 7 % by the first
day after the last of seven daily brushings before falling
back to baseline. These findings were similar in the cer-
vical lymph nodes draining the oral cavity, although the
return to baseline proceeded more gradually. Using a
PCR-based detection method [19], we found evidence of
P. gingivalis in the blood of B6.DR1 mice at 2 weeks and
in the maxilla 3 months after the last inoculation (data not
shown). There was no apparent change in the percentage
of regulatory T cells expressing Foxp3.
Production of ACPAs in response to treatment with
P. gingivalis
We measured ACPAs in sera from B6.DR1 mice treated
either with WT (W83) P. gingivalis or a PADnull mutant
(dPAD) using CCP2 ELISA (Axis-Shield, Alere, UK). The
sera were paired with those of WT C57BL/6 (B6) mice
brushed with either form of P. gingivalis to determine the
influence of the HLA-DRβ1 restriction element on the
production of ACPAs. We found (Fig. 2) that, relative to
B6 mice, B6.DR1 mice produced detectable levels of
ACPAs at 3, 4, and 8 weeks after brushing, but only when
brushed with a PAD+ form of P. gingivalis. Our data indi-
cated a direct relationship between HLA genotype and the
production of ACPA as well as demonstrating a role for
prokaryotic PAD enzyme in this process.
Cytokine production in response to treatment with
P. gingivalis
Serum samples from B6.DR1 mice were also used to
measure TNF-α, IL-1β, IL-17A, IL-10, IFN-γ, and IL-6
by multiplex cytokine analysis. We chose serial time
points in the weeks after the 7 days of treatment, but
also one at 9 weeks after the last treatment. We found
(Fig. 3) that relative to baseline values of the animals
before treatment (day 0), three of the proinflammatory
cytokines TNF-α, IL-1β, and IL-17A were elevated in P.
gingivalis-treated mice, whereas IL-10, IFN-γ, and IL-6
showed subtle or no changes.
a b
Fig. 1 Th17 response to oral challenge with live P. gingivalis. Healthy suspensions of live P. gingivalis were mixed with CMC and brushed onto
the gingival tissues of B6.DR1 mice (shaded pink area). a Contour plots for flow cytometric analysis of cervical lymph nodes and peripheral
blood mononuclear cells from individual B6.DR1 mice with or without treatment with P. gingivalis. Plots are gated on CD3+CD4+ T cells. Red numbers
in each quadrant represent the percentage of CD3+CD4+ T cells expressing the IL-17Fmrfp reporter, green numbers represent the percentage of
CD3+CD4+ T cells expressing the Foxp3gfp reporter. b Compilation of Th17 data over the course of 2 months after treatment. Results are
expressed as mean percentage of CD3+CD4+ T cells expressing IL-17Fmrfp. N = 3 or 4 mice at each time point. Error bars = SEM. GFP green
fluorescent protein, mRFP mono-red fluorescent protein (Color figure online)
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Bone loss in B6.DR1 mice following treatment with
P. gingivalis
We used μCT analysis to measure bone density in the
femurs of mice with or without P. gingivalis treatment.
Femurs from naïve mice were compared with femurs
from mice that were sacrificed 1 day or 16 days follow-
ing seven daily brushings with P. gingivalis. Decreases
in bone volume, bone volume fraction, and trabecular
thickness (BV, BV/TV, and Tb.th respectively; Figs. 4a, c)
indicating a loss of trabecular bone in the distal femur
were detectable at 1 day following P. gingivalis treatment,
and again at day 16 (green bars, Fig. 4c). Our calculations
revealed a mean distal trabecular bone volume of 0.149 ±
0.098 mm–3 for femurs from untreated mice, 0.052 ±
0.020 mm–3 for those from mice 1 day following the
last brushing with P. gingivalis, and 0.007 ± 0.005 mm–3
for those from mice at day 16. Bone volume fractions
followed an almost identical trend and trabecular thick-
nesses were 0.048 ± 0.001, 0.041 ± 0.002, and 0.028 ±
0.002 mm respectively (Figs. 4a, c).
In addition to a loss of trabecular bone, we also mea-
sured a loss of cortical bone by selecting a mid-shaft re-
gion of interest (Figs. 4b, c) and measuring the mean
cross-sectional tissue area. We found that the mean
cross-sectional tissue area was 2.0 ± 0.15 mm2 for femurs
from untreated mice, 1.8 ± 0.14 mm2 for femurs from
mice 1 day following the last brushing, and 1.5 ± 0.04 mm2
for femurs from mice at 16 days after the last treatment.
We also analyzed the phenotype of the T cells in the
cervical lymph nodes draining the oral cavity of each
mouse as it was sacrificed for μCT analysis of its bone
structure (Fig. 4d). We found that we could detect distinct
increases in the percentage of CD4+ T cells expressing the
Th17 phenotype of at day 1 and day 16 after treatment
with P. gingivalis with percentages rising from less than
1 % to nearly 4 % by day 16.
Finally, as might be expected from what other laborator-
ies have found in PD models, we also report that estab-
lished periodontal disease and periodontal destruction was
confirmed by detection of alveolar bone loss. As shown by
μCT densitometric analyses, we detected bone loss be-
tween the first and second maxillary molars from P. gingi-
valis-treated compared with untreated mice. The mean
alveolar bone density of P. gingivalis-treated mice was
695.8 ± 44.15 mg HA/cm3 vs untreated 819.4 ± 36.17 mg
HA/cm3 (N = 3/group, p < 0.05) (Fig. 4e).
Exacerbation of autoimmune arthritis following treatment
with P. gingivalis
The B6.DR1 mouse was developed to study autoimmune
arthritis on a common (B6) mouse background. We used
our well-developed arthritis protocols to determine whether
treatments with P. gingivalis would alter the expression
of disease through measurements of clinical incidence,
severity, paw index (the number of arthritic paws per
arthritic mouse), and bone loss. In this experiment, the
first two of the 39 CII/CFA-challenged mice had devel-
oped arthritis with a similar intensity at day 26 post
immunization, so they were divided pairwise into the
two treatment groups. Figure 5 demonstrates that brush-
ing with P. gingivalis results in a dramatic acceleration of
the disease expression, an enhancement of severity, and
an increase in the paw index. There was a statistically sig-
nificant increase in the percentage of arthritic mice in the






















B6.DR1-Pg B6.DR1-dPAD B6-Pg B6-dPAD
Fig. 2 Generation of antibodies to citrullinated protein antigens is
enhanced in mice bearing the transgene for human HLA-DR1β, and
requires PAD enzyme. Healthy suspensions of live P. gingivalis or a
PADnull mutant strain (dPAD) were mixed with CMC and brushed
onto the gingival tissues of dual-reporter B6.DR1 mice or WT C57BL/
6 mice. Serum samples were obtained 3, 4, and 6 weeks after brushing
and applied to commercial ACPA ELISA according to the manufacturer’s
instructions. Unbrushed mice generated no detectable ACPAs. The
supplied human secondary detection reagent was replaced with an
anti-mouse IgG2b antibody detection reagent suggested by the
manufacturer. N = 5 for each group. Error bars = SEM. ACPA
anti-citrullinated protein antibody, OD optical density
Fig. 3 Systemic proinflammatory cytokine response in P. gingivalis-
brushed mice. Serum samples from B6.DR1 mice brushed daily with
P. gingivalis were subjected to multiplex cytokine analyses. Cytokines
measured at day 0 represent those found in B6.DR1 mice prior to
P. gingivalis exposure. Limit of detection for each analyte was
between 0.8 and 10 pg/ml. Error bars = SEM
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Fig. 4 (See legend on next page.)
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treatments. Differences in incidence were statistically sig-
nificant almost immediately after the initiation of brushing
and were maximal by day 34, which was the last day of
brushing. Differences in severity and paw index were most
evident a few days after the last brushing. By day 35, only
28 % of the untreated group were arthritic whereas 74 %
of those brushed with P. gingivalis were arthritic.
P. gingivalis treatment breaks resistance to autoimmune
arthritis
We challenged a large group of mice with bovine CII
emulsified in CFA (CII/CFA) in order to elicit inflamma-
tory autoimmune arthritis. As in many previous experi-
ments, a small percentage (5–10 %) of the mice exhibited
a resistance to CIA and did not show any clinical signs of
(See figure on previous page.)
Fig. 4 Bone loss in response to oral challenge with live P. gingivalis. Healthy suspensions of live P. gingivalis were mixed with CMC and brushed
onto the gingival tissues of dual-reporter B6.DR1 mice. Legs were subjected to μCT analysis. a Proximal distal view of trabecular bone from mice
sacrificed 1 or 16 days following treatment with P. gingivalis relative to those from untreated mice. b Orthogonal gray-scale images of femurs (not
to scale). c Measurements of bone volume, bone volume fraction (bone volume/tissue volume), and trabecular thickness (BV, BV/TV, and Tb.th re-
spectively) for trabecular bone and mean cross-sectional tissue area for cortical bone. Regions of interest used to calculate these values are indi-
cated in b. d Flow cytometric analysis of cervical lymph nodes from corresponding mice at the time of sacrifice. Results expressed as mean
percentage of CD3+CD4+ T cells expressing the IL-17Fmrfp (red) and Foxp3gfp (green) reporter constructs. e Mean alveolar bone density in mice
treated with P. gingivalis or left untreated (N = 3/group, *p < 0.05). Error bars in c = SEM; error bars in e = SD. GFP green fluorescent protein, Pg Por-
phyromonas gingivalis, ROI region of interest (Color figure online)
Fig. 5 Exacerbation of autoimmune arthritis through brushing with P. gingivalis. Nineteen B6.DR1 mice were brushed daily for one week
with P. gingivalis (shaded pink area) and 18 mice were left untreated. Clinical measures of paw swelling were obtained in all groups
according to our standard protocol in which each paw is graded on a scale of 0–4 with 0 = no evidence of inflammation and 4 = maximally
inflamed. *Statistically significant differences in arthritis incidence between the no-treatment and P. gingivalis groups (p < 0.04 by chi-squared
test). ¶,#p < 0.01 by Student’s t test. ‡Paw index is calculated as average number of inflamed paws per arthritic mouse. §Severity index calculated as aver-
age severity per arthritic mouse. Results expressed as average ± SEM (Color figure online)
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disease. Seventy-six days after CII/CFA challenge we
brushed five of nine CIA-resistant mice with 106 CFU
of live P. gingivalis cells daily for 7 days. By 5 days after
the last treatment, all five mice had developed arthritis
whereas all four of the untreated mice remained CIA re-
sistant (Fig. 6a). This disease was characterized by typical
inflammatory infiltrates including the presence of nu-
merous TRAP+ osteoclasts in the tissues of P. gingivalis-
treated mice but a complete absence of pathology in the
untreated animals (Fig. 6b). While the severity of disease
was not as great as in the previous experiment (Fig. 5,
middle panel), the disease expression kinetics was similar
with two of the five mice developing signs of arthritis
before the last treatment with P. gingivalis.
Bone loss in P. gingivalis-treated arthritic mice
We used μCT analysis to examine the structure of bones
in the limbs of arthritic mice with or without P. gingivalis
treatment. We used specific bone-density measurements
to quantify the bone loss that happens as a result of the
disease process in CIA. When analyzing the density of the
entire paw, we were cautious in using specific anatomical
landmarks to be sure that we were measuring identical
structures on each sample analyzed, and compared paws
that had both identical clinical scores and identical onset
dates so that the disease duration over which the mea-
sured paw had experienced inflammation was comparable.
Our analyses of pedes (Fig. 7) revealed that, despite appar-
ent clinically similar severities (Fig. 7d & g), paws from
mice that had been brushed with P. gingivalis (Fig. 7h) ap-
peared to have greater damage and a lower overall bone
density than those that were not treated (Fig. 7e). An un-
involved pes from a mouse in the no-treatment group (7b)
had an average bone density of 859.5 mg HA/cm3, a fully
arthritic (CIA score of 4) pes from another no-treatment
mouse (Fig. 7e) had an average bone density of 850.56 mg
HA/cm3, whereas a fully arthritic pes from a P. gingivalis-
treated mouse (Fig. 7h) had an average bone density of
819.1 mg HA/cm3.
In addition to evaluating the overall density of the
entire paw structure, we determined that it was helpful
to focus the measurement on specific bones within the
a b
Fig. 6 Breaking resistance to autoimmune arthritis by brushing with P. gingivalis. a Nine B6.DR1 mice which had not developed arthritis at 76 days
post CIA challenge (green vertical line) were used for this experiment. Five mice (red squares) were brushed daily for 7 days (shaded pink area)
with P. gingivalis and four mice (blue circles) were left untreated. ‡Paw index is calculated as average number of inflamed paws per arthritic
mouse. §Severity index calculated as average severity per arthritic mouse. b TRAP staining of knee joints from P. gingivalis-treated and untreated mice.
Magenta staining identifies TRAP+ osteoclasts. ¶p < 0.05 by Student’s t test. Results expressed as average ± SEM (Color figure online)
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paw to give us a more sensitive measure of bone loss.
As an example, for the pedes we measured bone min-
eral density analysis of the first distal tarsal bone. The
first distal tarsal bone is located in the middle of the
pedes where the maximum pathology (clinical arthritic
score) is observed in the CIA model. This bone
(inset, Fig. 7b, e & h) has a high ratio of joint surface to
total bone volume, and is easily identified. The mean
bone mineral density of the first distal tarsal appears re-
duced in the P. gingivalis-treated mouse with CIA clin-
ical score 4 (inset, Fig, h: bone density 786.1 mg HA/
cm3), relative to that of both the uninvolved pes (Fig. b:
bone density 892.7 mg HA/cm3) and arthritic pes (Fig.
e: bone density 851.4 mg HA/cm3). Both 3D recon-
struction and radiographic imaging of the first distal
tarsal bone suggested significant structural damage in
the pes of the arthritic P. gingivalis-treated mouse com-
pared with the control mice without P. gingivalis treatment.
Representative histology of ankle sections (Fig. 7c, f & i)
underscores the inflammatory cellular infiltrates observed
in the arthritic mice. However, there were insufficient
numbers of comparable pedes in each group to provide
a statistical analysis, so we selected the metacarpal bone
of the fifth digit of the manus of a larger number of mice
(four groups of three each) in order to apply statistical
power to the study. The effect of P. gingivalis treatment in
relation to the development of autoimmune arthritis
(maximally inflamed manus, score = 4 vs no involvement,
score = 0) on the mean bone density of the V metacarpal
is shown in Fig. 8. While it did not reach statistical signifi-
cance, treatment with P. gingivalis triggered a trend to-
wards bone loss in the absence of clinically detectable
autoimmune arthritis. Moreover, development of auto-
immune arthritis was characterized by significant loss
in the bone density of the V metacarpal, as shown by μCT
densitometric analysis (CIA score 0, bone density 602.7 ±
13.29 mg HA/cm3; CIA score 4 bone density 405.5 ± 44.71;
P. gingivalis CIA score 0, bone density 512.8 ± 25.83; and
Fig. 7 Bone loss in pedes of P. gingivalis-brushed arthritic mice. μCT analysis of one non-involved (score = 0) pes from a no-treatment mouse,
one maximally inflamed pes (score = 4) from a no-treatment mouse, and one maximally inflamed (score = 4) pes from a mouse brushed with
P. gingivalis. a, d & g Photographs of pedes taken at euthanasia. b, e & h 3D reconstructions of bone morphology of each pes and of the first
distal tarsal with bone densities calculated according to an algorithm written specifically for that purpose. c, f & i Masson’s trichrome stained
sections of each corresponding ankle joint
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P. gingivalis CIA score 4, bone density 425.5 ± 55.1;
N = 3 manus/group; p < 0.01).
Discussion
Our study was designed to further understanding of the
underlying mechanisms that link PD to RA. Our goal
was to do this work in the context of a standardized
common mouse strain, C57BL/6, on which the vast ma-
jority of transgenes, knockins, and knockouts are found.
However, where arthritis is concerned, some laborator-
ies have reported variability in the CIA susceptibility of
C57BL/6 mice [21, 22], which may represent manifesta-
tions of differing intestinal flora [23]. We have circum-
vented this problem by generating an I-A°/I-E° mouse
on the C57BL/6 background that expresses a chimeric
mouse/human RA susceptibility allele HLA-DR1(*0101)
as a transgene. Recent research has suggested that this
same DR1 restriction element may also serve as a sus-
ceptibility allele for periodontal disease [24, 25], provid-
ing a unique opportunity for use as an animal model
that is perfectly suited for the analysis of linkages be-
tween the two disease processes. While there has been
one study in which HLA-DR4 tg mice were used to
look at the role of citrullinated human α-enolase [11], to
our knowledge no HLA-DR1 mice have been challenged
with P. gingivalis to assess its role in ACPA development
or modulation of arthritis.
There is abundant anecdotal evidence surrounding the
development of arthritis and other diseases following
dental procedures [26]. The prevailing hypothesis is that
chewing, brushing, and even the simplest dental procedures
can cause transient bacteremia and disseminate pathogens
in the bloodstream that may consecutively trigger systemic
health challenge, especially in susceptible hosts (i.e. im-
munocompromised patients). Our brushing technique and
model system was designed to mimic the introduction of
oral flora, including pathogens, into the periodontal tissues
of mice bearing the human class II MHC susceptibility
alleles, with stiff bristles attached to a syringe through
which healthy cultures of the Gram-negative anaerobe
P. gingivalis is delivered in a slurry of CMC. We wish
to establish a chronic P. gingivalis periodontal infection
that, compared with the ligature [27] and gavage [12]
models, does a better job of recreating the systemic
pulses of these oral pathogens into the mouse. The
ligature-induced PD model involves mechanical trauma
caused by ligature insertion and results in alveolar bone
loss, most likely due to the trauma (and possibly the
nonspecific bacterial plaque accumulation) that differs
from the classic bacterial etiology and pathogenesis of
PD independent of mechanical trauma. Furthermore,
the gavage of P. gingivalis may achieve an effective sys-
temic but transient bacterial challenge, while brushing
of P. gingivalis may facilitate the establishment of a
chronic infection of P. gingivalis in the periodontal tis-
sues and our findings suggest that it can trigger signifi-
cant pathological processes and autoimmune response
distinct and spatially removed from the inflammation
and alveolar bone damage seen in the ligature model.
Both PD and RA are known to be driven by the de-
velopment of proinflammatory Th17 cells which can
produce the cytokines known to be associated with the
destructive environment found in the RA joint and in
periodontal tissues [2, 28]. Cytokines produced by Th17
cells can drive the differentiation of osteoclasts from
precursors and these osteoclasts can tip the balance in
the direction of bone resorption [29]. In addition to
osteoclast increase, a recent study has shown that IL-
17A can decrease osteoblast formation resulting in a
net bone loss [30].
Our data demonstrate that a burst of Th17 cell gener-
ation takes place systemically because we can see a rise
in the percentage of CD4+ T cells expressing the Th17
phenotype and a subsequent rise in systemic levels of
IL-17A. We propose that this shift in T-cell phenotype
may give rise to both an increase in osteoclast formation
and a decrease in osteoblast formation, each of which
may contribute to the bone loss that we measured in
our μCT analyses.
Our analysis of serum cytokines demonstrates that
TNF-α, IL-1β, and IL-17A are all produced in response
to treatment with P. gingivalis, whereas other cytokines
such as IL-10 and IFN-γ are not produced, making any
changes in Th1-mediated activities unlikely. We expected
to see an increase in IL-6, a cytokine which works in
Fig. 8 Bone loss in manus of P. gingivalis-brushed arthritic mice. μCT
analysis of three metacarpal bones each from digit V of noninvolved
(score = 0) manus from mice with/without treatment with P. gingivalis,
and three metacarpal bones each from digit V of maximally inflamed
(score = 4) manus from mice with/without treatment with P. gingivalis.
Error bars = SD. **p < 0.01. NS not statistically significant. Pg
Porphyromonas gingivalis
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concert with TGF-β to activate the transcription factor
ROR-γt and drive the differentiation of Th0 cells into the
Th17 program. It is possible that the IL-6 may have been
expressed locally at the site of infection, or that it was an
early event which occurs prior to day 7.
If indeed a rise in Th17 levels is necessary to bring
about autoimmunity in the face of subclinical CIA, it
would be interesting to determine whether treatment
with a Th17-inducing prokaryote such as P. gingivalis
might have a similar effect on a Th1-dependent disease
such as antigen-induced arthritis.
One of the more interesting findings in our study was
that brushing with P. gingivalis not only increased arth-
ritis incidence and hastened its onset, but the paw index
and disease severity were also enhanced by statistically
significant values. At the end of the study, untreated
mice had an average of exactly two involved paws per
mouse whereas those brushed with P. gingivalis had an
average of 3.1 arthritic paws. The mechanisms driving
the paw index are as yet unknown, but one may pre-
sume that increasing the paw index might be similar to
the thresholds that drive incidence in a given study; once
that threshold is crossed, an individual mouse or individ-
ual paw may become arthritic.
One of the more intriguing findings in our study was
the evidence suggesting a role of HLA-DR1 in the gener-
ation of ACPAs. There is no shortage of clinical studies
[31–34] which have suggested that not only does ACPA
generation correlate well with the presence of the SE,
but that the fine specificity of ACPA epitopes may also
be shaped by it [35]. We asked whether the presence of
a transgenic expression of the SE could provide the ne-
cessary restriction element to allow a mouse to produce
ACPAs in response to brushing with P. gingivalis. We
chose to use a clinical diagnostic kit that is approved
for use in humans in order to determine whether the
chimeric mouse/human restriction element could drive
the generation of ACPAs in this model. Our results
clearly demonstrated that ACPAs were generated in re-
sponse to treatment with P. gingivalis, but only in mice
bearing the DR1 transgene and not in WT (B6) mice.
This suggests that the ACPAs being measured are linked
to the expression of the HLA-DR1 restriction element.
Furthermore, we also demonstrated that the generation of
ACPAs in this model required the expression of prokary-
otic PAD enzyme presumably to drive the citrullination of
host proteins. Together, these findings demonstrate a need
for both prokaryotic PAD and the HLA-DR1 restriction
element in order to drive the robust generation of ACPAs
in this model.
The end result of both periodontal disease and RA is
loss of structural integrity and function. In the case of
periodontal disease, this results in tooth loss; and in the
RA joint, cartilage is destroyed and bones are eroded
resulting in an ankylosis of the joint and loss of function.
While RA-induced bone loss and periodontal tooth loss
are very well documented in the clinical literature, and
bone loss has also been reported in animal models of ex-
perimental arthritis [36], to our knowledge direct measures
of nonalveolar bone loss resulting from the introduction of
an oral pathogen alone have not been documented. We
found a dramatic loss of trabecular bone and even a
modest loss of cortical bone following treatment with
P. gingivalis. In addition, μCT analysis in a limited
number of mice revealed bone loss dramatic enough to
result in actual fenestrations in the proximal tibia–fibula.
While this finding was limited to a small number of mice,
it highlighted the dramatic bone losses that could result
from treatment with P. gingivalis. We would propose that
the repeated systemic pulses of P. gingivalis in this model
drives a sufficient systemic Th17 response capable of
reducing osteoblast formation and generating sufficient
numbers of osteoclasts to reduce bone volume in the
extremities.
One of the most interesting findings in this study was
that mice which were otherwise resistant to the develop-
ment of collagen-induced arthritis could be induced to
rapidly develop clinical signs of autoimmune arthritis fol-
lowing oral exposure to P. gingivalis. Typical CIA induc-
tion experiments result in between 80 and 100 % incidence
among positive control mice. While it is unknown why
some of the mice treated exactly the same as others do not
develop disease, we were very interested to see that mice
which had not develop disease for more than 10 weeks
after challenge with type II collagen emulsified in CFA
could be rapidly induced to do so following oral exposure
to P. gingivalis. This suggests that if all of the disease-
inducing factors are already present, then an oral infection
could possibly tip the balance in favor of clinical expres-
sion of disease. The rapid onset of disease expression
(within 2 days) suggests that the generation of ACPAs
or antibodies directed at P. gingivalis would not likely
play a role in this induction. It is more likely that this
response is driven by innate immune pathways, and it
will be of great interest to elucidate the mechanism(s)
driving this interesting finding.
Conclusions
The B6.DR1 mouse allows us to examine the influence
of periodontal pathogens in the context of a relevant
human MHC class II restriction element HLA-DRβ1
during the development of autoimmune arthritis. This
restriction element provides the necessary framework
for the generation of ACPAs in response to infection
with an oral pathogen. From this study, it is clear that
treatment with the periodontal disease pathogen P. gin-
givalis not only exacerbates ongoing autoimmunity, but
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may also provide a trigger for disease development if
other disease-promoting conditions are present.
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